Search PubMed⌕ Search

Biomedical subjects

J Arai

Publications and source records attributed to J Arai.

At least 55 records · Page 3Linked to original sources
PubMed1994

[Clinical studies on cefozopran in pediatrics].

We conducted clinical studies on cefozopran (CZOP), a newly developed parenteral cephalosporin, for its clinical application in the field of pediatrics. 1. A clinical study was performed on 16 children with infections, including 9 with pneumonia, 1 each with acute bronchitis, enterocolitis, purulent lymphadenitis, 4 with skin and soft tissue infections. CZOP was administered by 30 minutes intravenous drip infusion. Doses varying from 20 to 35 mg/kg body weight were given t.i.d. Lengths of treatment ranged from 4 to 14 days. 2. Clinical efficacies were excellent in 10 and good in 6 cases, with an efficacy rate of 100%. The overall bacterial eradication rate for the pathogenic bacteria was also 100%. 3. Side effect was noted in 1 case with skin rash. Abnormal laboratory test data were found in 5 cases including slight elevations of GPT in 4 cases and GOT in 2 cases.

Adolescent↗
PubMed1993

Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney.

A 47-year-old woman who was homozygous for a silent cholinesterase gene (hereditary serum cholinesterase deficiency) presented with nephrotic syndrome and hyperlipidemia. Renal biopsy performed in 1986 demonstrated mesangial proliferative glomerulonephritis. Four years later, a second biopsy revealed progression with mesangial interpositions and severe lipid deposition in the glomeruli, tubules and interstitium. This is the first case of hereditary serum cholinesterase deficiency accompanied by renal disease. Serum cholinesterase deficiency may be related to hyperlipidemia and abnormal lipid deposition in the kidney, which promotes the progression of renal disease.

Adolescent↗
PubMed1993

[Nutritional assessment of patients on continuous ambulatory peritoneal dialysis].

Nutritional status was assessed in 214 CAPD patients from eight centers in Japan. All patients were receiving adequate dialysis, as indicated by KT/Vurea and Karnofsky's activity scale. Subjective global assessment indicated that 25% of 83 female patients and 27% of 131 male patients were, at least, moderately malnourished. Mid-arm muscle circumference was lower in malnourished male patients than in well-nourished patients, however, in female patients none of the anthropometric variables reflected nutritional status. Lower serum albumin level was observed in malnourished male patients, but not in female patients. Daily protein intake, estimated from protein catabolic rate (PCR) was approximately 0.8 g/Kg BW in both males and females. This value is similar to those reported in literatures for CAPD patients. In our well-rehabilitated patients, PCR did not reflect the nutritional status as indicated by subjective global assessment. The data suggest that low protein intake was not always the major cause of malnutrition in these patients and that other factors, such as endocrine disorder, may also have contributed to malnutrition.

Adult↗
PubMed1991

[Imaging diagnosis of periventricular leukomalacia].

The neurodevelopmental prognosis of periventricular leukomalacia (PVL) has been predicted effectively by ultrasonography (US). US is the best imaging modality to identify both the early changes of PVL (echogenic phase) and the late changes (cystic phase). In cases with intraventricular hemorrhage, however, it was difficult to differentiate from periventricular hemorrhage in the echogenic phase by US. The PVL resolved to a discrete cyst separate from the ventricle, but periventricular hemorrhage developed a porencephalic cyst. Computed tomography is useful for distinguishing periventricular hemorrhage from PVL in the early changes. However, it is not particularly useful in the late changes, as only extensive cystic lesions can be seen. Magnetic resonance imaging is useful for following the progress in myelination.

Humans↗
PubMed1990

Stable isotope 15N-urea and clinical research in nephrology.

Stable isotope 15N-compound, 15N-urea, is useful marker to investigate nitrogen metabolism in clinical nephrology, particularly in chronic renal failure or dialysis. 15N-urea incorporation into plasma albumin in addition to plasma 15N disappearance was studied in 6 patients with endstage chronic renal failure. As a result, only minor fraction of administered 15N-urea was incorporated into albumin in this study. In addition, it was also confirmed that high energy diet may promote protein synthesis through 15N incorporation to plasma amino acids, such as alanine, in these patients with low protein meal. Therefore, administration of 15N-compound to human subjects may contribute to provide us the important informations on nitrogen metabolism. For instance, urea kinetics are described in the endstage chronic renal failure in this review. However, less expensive 15N-compounds should be provided and more simple but accurate measurement of 15N activity should be developed for the further clinical application of the stable isotope.

Adult↗
PubMed1989

Effects of dietary protein intake on renal function in humans.

The effects of an acute protein load on renal hemodynamic responses and plasma glucagon levels were investigated in 31 patients with biopsy proven chronic glomerulonephritis (24 cases) or chronic renal failure (6 cases). After baseline clearance measurements, the subjects ingested a high protein meal consisting of 1.2 to 1.5 g protein/kg body weight in the form of cooked beef followed by a second set of measurements. This acute protein load resulted in a rise of both creatinine and PAH clearances (from 86.5 +/- 6.0 ml/min to 98.3 +/- 7.1 ml/min and 531.1 +/- 59.1 ml/min to 688.9 +/- 72.9 ml/min, respectively). This was associated with an elevation of plasma glucagon levels from 104.6 +/- 7.9 pg/ml to 134.5 +/- 7.5 pg/ml. From these data we suggest that the augmentation of renal function following a high protein intake may be mediated by the simultaneous rise of plasma glucagon levels, and that the glucagon concentration in the portal vein rather than in the peripheral blood has a pivotal role in this setting.

Adolescent↗
PubMed1985

Metabolic conversion of alpha-keto valine to valine in patients with chronic renal failure.

Change in the metabolic conversion rate of alpha-keto valine to valine following oral administration of the analog of the essential amino acid (0.1 g/kgB.W.) is studied in six patients with chronic renal failure and five control subjects under low protein, low and normal energy intake diets. Diet I is composed of 105 kj (25 kcal)/kgB.W. energy and 0.6 g/kgB.W. protein, whereas Diet II is composed of 165 kj (40 kcal)/kgB.W. with the same amount of protein intake. As a result, an increase in plasma keto valine concentration is observed immediately after oral administration, followed by an increase in plasma valine concentration, implying that metabolic conversion of alpha-keto valine to valine occurs within a small amount of time. In addition, the conversion rate appears to be accelerated under Diet II. It is therefore suggested that reutilization of urea nitrogen with the ketoanalog under the low protein diet seems to be promoted under adequate energy intake.

Administration, Oral↗